الولايات المتحدة · منصات وبيانات · Benzinga

Pfizer Pulls Menopause Hormone Therapy Premarin From Canadian Market

نشره Benzinga · الولايات المتحدة منذ 34 د

ملخص مفصل

Pfizer Inc. (NYSE:PFE) will reportedly no longer sell its hormone replacement therapy Premarin in Canada following an internal review, ending Canadian availability of both its…

اقرأ المقال كاملًا على Benzinga سجّل الدخول للحفظ

يعرض MarketNews العنوان والملخص كما نشرتهما الوسيلة الإعلامية. المقال الكامل متوفر على موقع الناشر. (www.benzinga.com)

يستحق القراءة أيضًا

MarketWatch

Chicago Fed's Goolsbee says central bank 'has definitely got work to do' on inflation

Investing.com

Wolverine World Wide stock hits 52-week high at 23.85 USD

Yahoo Finance

Pfizer Pulls Menopause Hormone Therapy Premarin From Canadian Market

ملخص مفصل

مشاركة

يستحق القراءة أيضًا

The 2027 401(k) limits are here. See how much more you can save next year.

Democrats Sweep Congress: What History Says Comes Next for Stocks

Sumitomo Mitsui Financial GAAP EPS of ¥232.59, total operating income of ¥1.43B

Chicago Fed's Goolsbee says central bank 'has definitely got work to do' on inflation

Wolverine World Wide stock hits 52-week high at 23.85 USD

Global Defense Tactical Communication Market Report 2026: Capitalize on 6.8% CAGR Through 2030